Key result
Cardiovascular disease is a significant burden among cancer patients in the United States, driven by overlapping risk factors, systemic inflammation, and anti-cancer therapies.
No takes yet. Share an insight, caveat, or question.
Highlights the importance of addressing cardiovascular disease and treatment-related complications among patients with cancer, with a focus on racial disparities in the US.
Thotamgari et al. (2022) conducted an editorial in Cardiovascular disease in patients with cancer. Cardiovascular disease is a significant burden among cancer patients in the United States, driven by overlapping risk factors, systemic inflammation, and anti-cancer therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: